Publications by authors named "Jochen Utikal"

Claim this Profile
G
Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells.
Juliane Poelchen, Sandra Pardo, Daniel Novak, Qian Sun, Tamara Steinfass, Jochen Utikal

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.
Selma Ugurel, Nessr Abu Rached, Thilo Gambichler, Miriam Mengoni, Thomas Tüting, Jochen Utikal

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Jochen Utikal

Mol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracorporeal photopheresis therapy rapidly changes the cytokine profile and tumor microenvironment in cutaneous T cell lymphoma.
Susanne Melchers, Luisa Tengler, Özge Ç Şener, Paul L Beltzig, Ronny Schmidt, Jochen S Utikal

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse features.
Wesley Y Yu, Ani Pazhava, Marie B Weitemeyer, Lisbet R Hölmich, Iva Johansson, Jochen Utikal

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, Michael Weichenthal, Peter Mohr, Jochen Utikal

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermal Mitoses Correlate with Surgical Burden in Lentigo Maligna Melanoma: PRAME for Margin Assessment.
Thomas Leibing, Clara Ziemann, Cyrill Géraud, Jochen Utikal, Sebastian A Wohlfeil

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of primary cutaneous angiosarcoma versus radiation-induced angiosarcoma: A cohort study.
Jochen S Utikal, Sebastian A Wohlfeil, Christiane Bauer-Auch, Tilo Vogel, Anna-Lena Koy

J Eur Acad Dermatol Venereol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticotropin-Releasing Hormone in Melanoma and Nonmelanoma Skin Cancer.
Marcel Mueller, Susanne Melchers, Iris Mueller, Jochen Utikal, Julia Krug

J Skin Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIPK4 accelerates cutaneous squamous cell carcinoma progression by phosphorylating TAp63 and inhibiting EFEMP1 expression.
Ze Guo, Bingjie Chen, Mengya Zhang, Min Gao, Zaixing Wang, Jochen Utikal

J Biol Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion.
Yiman Wang, Ke Liu, Yuxin Zhang, Daniel Novak, Aniello Federico, Jochen Utikal

Cell Death Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors.
Oliver Bechter, Carmen Loquai, Stephane Champiat, Jean-Francois Baurain, Jean-Jacques Grob, Jochen Utikal

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG.
Sören Reinhard, Jochen Sven Utikal, Anne Zaremba, Georg Lodde, Imke von Wasielewski

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatologist-like explainable AI enhances melanoma diagnosis accuracy: eye-tracking study.
Tirtha Chanda, Sarah Haggenmueller, Tabea-Clara Bucher, Tim Holland-Letz, Harald Kittler, Jochen S Utikal

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma.
Qian Sun, Nina Wang, Juliane Poelchen, Mareike Peter, Daniel Novak, Jochen Sven Utikal

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Unique Signature for Cancer-Associated Fibroblasts in Melanoma Metastases.
Saskia Tauch, Joschka Hey, Bettina Kast, Nicolas Gengenbacher, Lena Weiß, Jochen Utikal

Pigment Cell Melanoma Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status.
Jan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, Patrick Terheyden, Jochen Utikal

Front Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg.
Andrea Forschner, Katharina C Kähler, Martin Gschnell, Ewan A Langan, Carsten Weishaupt, Jochen Utikal

Front Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of refractory, locally metastatic squamous cell carcinoma of the leg with isolated limb perfusion: a case report with unexpected long progression-free interval.
Danai-Dionysia Kanatoula, Sebastian A Wohlfeil, Jens Jakob, Peter Hohenberger, Jochen Utikal

Front Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimethyl fumarate and extracorporeal photopheresis combination-therapy synergize in inducing specific cell death and long-term remission in cutaneous T cell lymphoma.
Özge Ç Şener, Susanne Melchers, Luisa Tengler, Paul L Beltzig, Jana D Albrecht, Jochen S Utikal

Leukemia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition.
Yasmin F Melzer, Nadine L Fergen, Christian Mess, Julia-Christina Stadler, Glenn Geidel, Jochen Utikal

Transl Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg.
Julian Kött, Tim Zell, Noah Zimmermann, Alessandra Rünger, Daniel J Smit, Jochen Utikal

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance, accuracy and reproducibility study of pathologists' diagnosis of melanoma and melanocytic tumors.
Sarah Haggenmüller, Christoph Wies, Julia Abels, Jana T Winterstein, Lukas Heinlein, Jochen S Utikal

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care.
Lukas Heinlein, Roman C Maron, Achim Hekler, Sarah Haggenmüller, Christoph Wies, Jochen S Utikal

Commun Med (Lond)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling.
Feyza Gül Özbay Kurt, Beatrice-Ana Cicortas, Bianca M Balzasch, Carolina De la Torre, Volker Ast, Jochen Utikal

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis